Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Interstitial Lung Disease
60%
Prevalence
60%
Diagnosis
56%
Myositis
39%
Amyloidosis
30%
Autoimmune Pancreatitis
30%
Lupus Erythematosus
30%
Enteritis
30%
Urticarial Vasculitis
30%
Complement Component C1q
30%
Statin
30%
Systematic Review
30%
Cardiovascular System
30%
Dyslipidemia
30%
Polymyositis
30%
Vasculitis
30%
Rheumatology
30%
Psoriatic Arthritis
30%
Case Presentation
30%
Spondylarthritis
30%
Polymyalgia Rheumatica
30%
Fibromyalgia
30%
Idiopathic Interstitial Pneumonia
24%
AA Amyloidosis
20%
Retroperitoneal Fibrosis
15%
Endoscopic Retrograde Cholangiopancreatography
15%
Azathioprine
15%
Raynaud Phenomenon
15%
Jo 1 Antibody
15%
Orthopnea
15%
Pancreatitis
15%
Methotrexate
15%
Muscle Weakness
15%
Gastrointestinal Distress
15%
Hepatobiliary System
15%
Arthralgia
15%
Abdominal Pain
15%
Magnetic Resonance Imaging
15%
Dyspnea
15%
Myalgia
15%
Corticosteroid
15%
Dysphonia
15%
Autoimmune Disease
15%
Dermatomyositis
15%
Skin Defect
15%
Chronic Inflammation
15%
Biopsy Technique
15%
Disease
11%
Systemic Scleroderma
9%
Salivary Gland Biopsy
9%
Capillaroscopy
9%
Lymphadenopathy
9%
Trachea Compression
9%
Bile Acid
9%
Omega-3 Fatty Acid
9%
Recurrent Disease
9%
Niacin
9%
Drug Therapy
9%
Primary Prevention
9%
Side Effect
9%
Hypercholesterolemia
9%
Secondary Prevention
9%
Ezetimibe
9%
Lung Function Test
9%
Respiratory Medicine
9%
Rheumatoid Arthritis
9%
Pulmonary Fibrosis
9%
Inflammatory Disorder
9%
High-Resolution Computed Tomography
9%
Rheumatic Disease
9%
ANCA Associated Vasculitis
9%
Neck
9%
Inflammatory Arthritis
9%
Sacroiliitis
9%
Chronic Disease
8%
Cohort Effect
8%
International Classification of Diseases
8%
Demography
8%
Intestinal Wall
7%
Autoimmunity
7%
Lupus Nephritis
7%
Rituximab
7%
Glucocorticoid
7%
Clinical Significance
7%
Immunomodulating Agent
7%
Self-Medication
6%
Health Care
6%
Patient Referral
6%
Denial
6%
Diagnostic Error
6%
Social Network
6%
Clinician
6%
Antiinflammatory Agent
5%
Pelvic Girdle
5%
Corticosteroid Therapy
5%
Disease Modifying Antirheumatic Drug
5%
Functional Limitation
5%
Biological Product
5%
Biological Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
66%
Psoriatic Arthritis
33%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
30%
Dyslipidemia
30%
Wasp Sting
30%
Rheumatic Polymyalgia
30%
Fibromyalgia
30%
Alirocumab
30%
Evolocumab
30%
Proprotein Convertase 9
30%
Geographic Distribution
30%
ICD-10
30%
Low Density Lipoprotein Cholesterol
30%
Psoriasis
30%
Dermatomyositis
30%
Arthritis
30%
Inflammatory Bowel Disease
30%
Cardiovascular Disease
30%
Nicotinic Acid
15%
Omega-3 Fatty Acid
15%
Fibric Acid Derivative
15%
Ezetimibe
15%
Bile Acid
15%
Hypercholesterolemia
15%
Recurrent Disease
15%
Side Effect
15%
Statin (Protein)
15%
International Classification of Diseases
12%
Disease
11%
Biological Product
8%
Myositis
7%
Skin Defect
7%
Muscle Weakness
7%
Self-Medication
6%
Disease Modifying Antirheumatic Drug
5%
Giant Cell Arteritis
5%
Chronic Disease
5%
Antiinflammatory Agent
5%
Immunology and Microbiology
Systemic Lupus Erythematosus
60%
Prevalence
60%
Systemic Scleroderma
30%
Inflammatory Arthritis
30%
Immunology
30%
Cytokine
30%
Enteritis
30%
Lupus Erythematosus
30%
Myositis
20%
Polymyositis
20%
Autoimmune Disease
17%
Dermatomyositis
9%
Methotrexate
9%
Raynaud Phenomenon
9%
Jo 1 Antibody
9%
International Classification of Diseases
8%
Immunomodulating Drugs
7%
Glucocorticoid
7%
Autoimmunity
7%
Blood Plasma
5%
CX3CL1
5%
Granulocyte Macrophage Colony-Stimulating Factor
5%
Tumor Necrosis Factor
5%